BACIBACT

Main information

  • Trade name:
  • BACIBACT 250 IU / g + 5 mg / g cutaneous powder
  • Dosage:
  • 250 IU / g + 5 mg / g
  • Pharmaceutical form:
  • cutaneous powder
  • Prescription type:
  • No Prescription (OTC)
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • BACIBACT 250 IU / g + 5 mg / g cutaneous powder
    Finland
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • Neomycin
  • Product summary:
  • Previous_names: BACIMYCIN; Suitability for use in older adult patients Bacitracinum Suitable for older persons. For short-term use only on a limited area of skin. In topical use, absorption takes place through mucous membranes and broken ski. Neomycini sulfas Suitable for older persons. For short-term use only on a limited area of skin. In topical use, absorption takes place through mucous membranes and broken ski.

Status

  • Source:
  • Fimea
  • Authorization status:
  • Marketing authorization granted
  • Authorization number:
  • 743
  • Authorization date:
  • 25-04-2006
  • Last update:
  • 26-07-2018